These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12393462)

  • 1. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster.
    Jankowski M; Vreys I; Wittevrongel C; Boon D; Vermylen J; Hoylaerts MF; Arnout J
    Blood; 2003 Jan; 101(1):157-62. PubMed ID: 12393462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
    Arvieux J; Roussel B; Pouzol P; Colomb MG
    Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
    Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
    Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
    Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants.
    Shi W; Chong BH; Chesterman CN
    Blood; 1993 Mar; 81(5):1255-62. PubMed ID: 8443387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies and thrombosis.
    Brighton TA; Chesterman CN
    Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies.
    Safa O; Esmon CT; Esmon NL
    Blood; 2005 Sep; 106(5):1629-35. PubMed ID: 15890686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles.
    Galli M; Bevers EM; Comfurius P; Barbui T; Zwaal RF
    Br J Haematol; 1993 Mar; 83(3):466-72. PubMed ID: 8485053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes.
    Lutters BC; Meijers JC; Derksen RH; Arnout J; de Groot PG
    J Biol Chem; 2001 Feb; 276(5):3060-7. PubMed ID: 11053420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants.
    Arnout J; Vermylen J
    Lupus; 1998; 7 Suppl 2():S23-8. PubMed ID: 9814667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies.
    Pierangeli SS; Liu SW; Anderson G; Barker JH; Harris EN
    Circulation; 1996 Oct; 94(7):1746-51. PubMed ID: 8840870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cofactor-independent human antiphospholipid antibodies induce venous thrombosis in mice.
    Manukyan D; Müller-Calleja N; Jäckel S; Luchmann K; Mönnikes R; Kiouptsi K; Reinhardt C; Jurk K; Walter U; Lackner KJ
    J Thromb Haemost; 2016 May; 14(5):1011-20. PubMed ID: 26786324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.